Tregitope peptides: the active pharmaceutical ingredient of IVIG? - Wikidata - awgldk - TriplyDB

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

http://www.wikidata.org/entity/Q37456938

about

Immune camouflage: relevance to vaccines and human immunology.Classification model of amino acid sequences prone to aggregation of therapeutic proteins.

P2860

Q39080439-D90DDFB9-7BF3-4770-A6A1-75ADFB6112B9 Q42428682-DC59AED2-281E-4352-B0AF-3FB959A12900

P2860

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

http://www.wikidata.org/entity/Q37456938

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@en

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@nl

type

label

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@en

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@nl

prefLabel

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@en

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@nl

P1433

Q37456938-8505C6F4-7037-4449-BF88-3081C73E811F

P1476

Q37456938-8C1B2D05-C523-404A-A9DB-BFE0F50CFB3C

P2093

Q37456938-34C92E4C-699A-441E-95FD-F212C6149C4F

Q37456938-34CCF420-C7CC-45D9-878F-7862ABABBFDF

Q37456938-D6D97018-2D34-4C2E-89EC-9A81D794ACFA

P275

Q37456938-482F60CB-193B-4189-8C4D-B8EC7A901BF3

P2860

Q37456938-05BA2F25-B58F-4C67-A925-C8A97940C773

Q37456938-05DA4A42-FF56-4D61-BCD9-6ACC005F1607

Q37456938-062EAF54-3258-4261-8BF9-A73985970601

Q37456938-07149A39-469A-4E47-91F8-11F87873EA85

Q37456938-079683CA-6DE0-493E-B307-5E77538A3C65

Q37456938-0C412F9C-C48B-4CB4-9884-9E06D135360D

Q37456938-12971529-9E64-47D1-9EFE-9B49469B6103

Q37456938-1EE197DC-A432-445E-BAC8-217F9FD9D1D2

Q37456938-26037248-A887-475C-AE29-7B8FF6FAD2B7

Q37456938-2B231EF4-3AEB-4E75-B9B3-74CE36A1E922

P304

Q37456938-2553DD09-1ADE-4611-9225-2AEFF3C38DC3

P31

Q37456938-1454F5B6-ED82-41B8-8D21-7F2016FAE866

Q37456938-223AC281-260E-4C84-926C-5E12B019AD9B

P356

Q37456938-6FE5E793-C5BD-4AD9-AE48-9B20B72FFA09

P478

Q37456938-410BEB6C-90A2-43D0-B537-636D70343D17

P50

Q37456938-C2DA9B61-552B-4795-BB24-763957CDD6A7

P577

Q37456938-288FE8AE-928B-4AE3-B1C6-E87D7E94FDC9

P5875

Q37456938-104C9FCF-0CD6-44D9-B079-2D2F51DBB702

P698

Q37456938-27D1F314-54B1-4547-9E85-14A05427845B

P921

Q37456938-168D7122-B62C-41EF-AFBD-243278F945D7

Q37456938-6B688FB3-E9F9-4A78-B702-9C3D15617B9F

Q37456938-8468F77A-23D6-4613-9B5F-D3F1B28B5796

Q37456938-D1D7E647-5EAE-4427-B662-BAC459F88C0F

Q37456938-EB869AE6-FD35-496E-958A-4F045C9668D8

P932

Q37456938-E7E1BB9A-6F7F-4600-A9CA-4F5976E60C38

P356

P1433

Clinical and Developmental Immunology

P1476

Tregitope peptides: the active pharmaceutical ingredient of IVIG?

@en

P2093

Federico Mingozzi

http://www.w3.org/2001/XMLSchema#string

Leslie Cousens

http://www.w3.org/2001/XMLSchema#string

William Martin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

Tregitope update: mechanism of action parallels IVIg

Immune supplementation and immune modulation with intravenous immunoglobulin.

Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se.

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.

Multi-modal antigen specific therapy for autoimmunity.

P304

493138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/493138

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Anne Searls De Groot

P577

2013-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259879275

http://www.w3.org/2001/XMLSchema#string

P698

24454476

http://www.w3.org/2001/XMLSchema#string

P921

T-lymphocyte subsets

lymphocyte subsets

hemic and immune systems

P932

3886585

http://www.w3.org/2001/XMLSchema#string